New Zealand CSO: I have to use my network
Timing was crucial in Torsten Hoffmann’s decision to leave Roche to become the new CSO of Zealand Pharma. The scientific director wants to put his extensive network to good use in the search for a partner.
by Stefan Singh Kailay
When Torsten Hoffmann agreed to become the next Chief Scientific Officer of Danish company, Zealand Pharma, thus leaving Roche, his workplace for the past 16 years, timing was the crucial factor.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler:
.jpg)
Christian Grøndahl becomes CEO
For abonnenter
.jpg&w=384&q=75)
